ClinicalTrials.Veeva

Menu

Clinical Investigation of the F-Composite 2 System in Direct Filling Therapy

Ivoclar Vivadent logo

Ivoclar Vivadent

Status

Completed

Conditions

Dental Caries
Unsatisfactory or Defective Restoration of Tooth

Treatments

Device: F-Composite 2 system

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The objective of this study is to evaluate the clinical performance of F-Composite 2 system in Class I and Class II cavities in permanent teeth.

The materials of the system can be polymerized in short time with a curing light which is part of the system.

The study will be carried out as a prospective study, with evaluation of the restorations after 7-10 days (baseline), at 6 months, at 12 months, at 24 months and 60 months according to defined criteria.

Enrollment

50 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Indication for direct filling of Class I or II with permanent premolars or permanent molars
  • replacement of insufficient fillings (e.g., due to edge caries, filling fracture, Lack of quality of the surface, lack of aesthetics, undesirable filling material, leaky edge, edge gap, etc.)
  • extensive primary caries
  • Vital tooth (cold test)
  • One-, two- or three-surface fillings in the lateral tooth area, with a maximum of 25% single-faced (Class I) with antagonists.
  • The occlusal area of the filling must be at least 1/3 of the total area of the filling tooth. This criterion is estimated.
  • Patient wishes to receive care within the framework of the study (written consent after detailed elucidation and study of patient information).
  • Maximum of 2 restorations per patient.
  • Preoperative complaints on the tooth to be restored (maximum 3 on visual Analog scale (0 = complaint-free, 10 = maximum possible pain) to temperature or bite sensitivity
  • Sufficient language skills

Exclusion criteria

  • Unfinished hygiene phase or poor oral hygiene
  • Sufficient draining of the operating field is not possible
  • Patients with proven allergy to one of the ingredients of the materials used
  • Patient has allergies to local anesthetic agents Ultracain DS (active substance: articaine; Vasoconstrictor), if anesthesia is desired
  • Patients with severe systemic diseases
  • Devital or pulpitic teeth
  • Periodontal insufficiency
  • Supplements with cusp attachments
  • open side bite
  • missing antagonist
  • Indication for direct capping
  • Pregnancy (women of childbearing age receive a free pregnancy test for self application, the negative result of which is shown with her confirmed consent).

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

F-Composite 2 system
Experimental group
Description:
Tooth (teeth) affected by dental caries or with an existing defective filling will be restored using the F-Composite 2 system.
Treatment:
Device: F-Composite 2 system

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems